An article written by International Life Sciences Chair Cheryl Reicin and Associate Luke Jeagal was published in BIOTECanada's Insights Magazine focusing on how life sciences companies should structure themselves so that they have cross-border opportunities.

The authors write, "If a company wishes to change its parent company from a Canadian entity to a US entity after the enterprise has real value, it can have costly tax consequences or require a complex structure to avoid such consequences.”

Source

BIOTECanada Insights Magazine